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90A ,%II,',;TI~,ACI'~ Or;d ],\(,(" I:chru~tr.~ I ,~)}~ 
(trenscranlol Doppler) woro continuously recorded in 15 ~ubjects undergoing 
tilt labia to~ting lor ovak~0tion of sync0po, Th0, pulsatlllty index (PI = (Vm,=, 
V,.,.)N,.,,,.) and the CBF velocity corrected tot Iteart rote (CBFV, = velocity 
mtogral/provloug RR interval) wore plotted against lime, 
Re,~ults: Fight man I~od positive tilt rocpongo[~ (55 ,  11 yrs) and 7 pallonls 
(6 men, 1 womsn. 45 t. 9 yr8), had n0gative responses, Tl~o last 4 minute of 
herr¢odyn[tmic recordings ore displayed In tl~e Figure. At time "0" in the Till(+) 
g~oup tit0 lowest MAP was recorded. The ro{ItJctlon in CI~FV,: occurred arrd 
w,~ greatest prior to II~o MAP loll In the Till(*) pottont~, The toll in CLaFV~ 
bogcm prior to that of the MAP (breakpoint analysis), The.] was no clr0ngo 
in CI3FV in th0 Till( ) ~ubj0c(~, 
r~lll rill( I 
Cenclusioa,,~ In TIII(~) ~|lblUCts C[~FV ttlflltll ttllllng bolole MAP, 5UggOSl- 
Ifl o that the triggering event m syncope vn[ty ba cenlral, and lh¢d tilt) syslem=c 
v~5odilr~f~tion OCcuca I~tter 
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. , .  course of . . r ,  Rs,o o.d .ear, Ro,o ,,ar,ab,,,,y 
~'~ Before Spontaneous ~ustalnad Ventrlcular 
'll~chyeardla 
K.P, Anderson, V. Shusferman, El. Ay~in, S ~odo, V Gon=paty, 
O, Schwadzman. For fire ESVEM Invesfigafor~, University of Pittsb~ugh, 
P~ffsburgh, PA, USA 
Alterations in autonomic nervous ~ystem activity (ANSA) padicipatn ~n m- 
rhythmegenos+s but little informatio~ o}(ists on the time course el Such effects 
TO address the hypothesis that e window el oppodunity exists during which 
preventive Interventions could be employed, we examined the changes in 
heart rote (HR) and HR variability indices (HRVi), which reflect ANSA, prior 
to the onset of spontaneous sustained monomorphic vontncular taehycardia 
(VT.~,,,,). 
Methods: Hotter ECGs with VT~,.. recorded from 40 pahents (pts) in the 
absence of anliardrythmic drugs were analyzed, Power m yon/ low (VLF 
00033-004 Hz), low (LF: 004-0,15 Hz) ~nd high (HF: 015-O4 H~) fre- 
quency ranges and Iotal power (TP) wore estimated in 5 and 15 m=n segments 
over the 24 hr period and Iogaritl~mtcally tranSform0d, 
Results: Mean HR rose gradual!y bolwocn 3 and 2 hr, thee accelerated t 
hr before MT~.~., The mean rates of decline in RR interval at 3 hi, 2 br, 1 hr, 
30 rain and 15 rain before VT~.~., wore, respectively, 0164 * 1.187, 0.062 
t 0,988, 110 , 2.23, 1,B6 * 5.22 and 1.85 * 4.9g ms/min. HR was higher 
1-2 hr before the onset of VT~,~,,, compared to 3 I~r in 31 pts (65%), HR began 
to rise in 32% el these pts at 2 hr. in 16% each at 60. 45, and 30 min, and in 
20% at 15 rain. Changes in HRVi began between 2 and 1 hr with the most 
prominent changes 30 rain before VT~,. compared to averages over 24 hr 
(VLF: from 6,49 ~ 1,301o6.18 t 1,021nnrs:.p =0.037, LF: from 5,43 t 
1.35 to 5,14 ~ 1,46 In ms;', p = 0,004, HF: from 4.64 ~ 0.99 to 4.45 .. 1.20 
In ms;', p = 0,03, LF/HF: from 0.91 : 1 12 to 0.76 ~ 1.14, p = 0.011). 
ConckrSlons: Evidence of altered ANSA activity preceding VT,~., was 
detected i0 31t48 (6500) of the pts. A time period between the onset of 
delectable HR and HRVi indicators of ANSA of at least 15 min was present in 
B0% Of 31 pts. and in 3~% a time window :-60 min was present. Preventive 
interventions may be feasible in subsets of pts with VT~.  
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~3-3  Sinus Cycle Shortening During Ventrieular 
Tachycardia Predicts Better Than Ventricular 
Funct ion Major  Events in the Fo l low-up  
M I.andolina. G.M. De Ferrari, M. Mant~a. R. Manfredini, P.D. 3ella, 
A. Vincenti, S. Remano Oept of Cardiology, IRCCS Osp Maggiore and 
Centre F~siolog~a Chn~ca. University el Milano, Mtlano. Italy 
Sinus node (SN.) reflex response during induced ventricular tachycardia 
(VT) is likely to be related to autonomic reflex modulation and may therefore 
provide prognostic information. 
This study assessed the prognost;c value of the percentage shortening 
of S.N cycle 30 s after the induction of VT with V-A dissociation, compared 
to the baseline valttes, in 50 pie rage 65 :t 8 years, LVEF 36 t 11%) with 
clinical suslolnod VT after myocardial infarction. 
Survival vs S.N. cycle shortening 
"°. F~..=~, . . . . .  
° t ,,t 20% 
Follow-up (mot~) 
Survival v8 LVEF 
1,0 ~'"1  
FOllOw-up (moo) 
DL!rmg a medi,~n fOllOw-Up of 16 months, 7 pts had ~ cardiac death and 2 I 
a VT recurrence Kaplnn.Mei0r event-boo survival c~Jlrv~s howe~ thai S IN  
cyclo shortening - P0% In ~ ~0) was associated with a slgnihcant|y incrg~s~d 
=ate el meier events, An impa!md LVEF l- 35%) (n =. 30) w~s a markedly 
pOorer predictor of nraior events. By multivanato analysis only SN. Cycle 
shortening was a significant independent predictor (p = 0 Q00I) 
Thus, ~ blunted SN response to VT is a marker el madequate autor~m~c 
m0dalahon that can earn/independent prognostic interm~t~on 
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F- - - _ I  .dro.ho.lum .yd.och,or,do Ms  .o, E,e.,o 
. . . . .  Ventrlcular Fibrillation Thresholds in Humans 
RD. M=frani. A. Intenan. Jr, J Dylewsk=, EM Kloosterman. S Atapattu 
L Munoz, A. Castellanos, R J Myerbufg t. aversity el M~ami School ot 
Medzcine, MlamL Florida. USA 
Intravenous phenylephrine levates vent0cular fibrillation (VF)thresholds m 
humans and animal models, presumably by bare(rex activation and reduced 
sympathetic activity. To determme whether direct vagomimelic activity u~mg 
edrophonium ted) has a similar effect, we studied 15 patients (mean age 60 
years) wilh ischemie and nonischemie cardiomyopathy dunng VF induction 
tVFI) as pad el dolibnllator Lmplantation or evaluation. Nine patients had VF 
reduced at baselme and alter Ed (10-15 rag) inlusion, while 6 patients se~ed 
as conhol and had 2 VFIs without Ed. The VIFI protocol was: T wave shocks 
(0.1-.4 joules) in a stepwise design. 10-30 msec alter, during or bolero the 
T wave peak. untd VF was induced. In the patients receiving Ed. the head 
rate decreased hem 72/minute at baseline to 67~minute IP = 0.07) while the 
control patients' head rate did not change (72 versus 711minute) between 
VFI 1 and 2 The number of attempts to induce VF on the 2 "~ versus 1 ~ 
attempt was not signilicantly different in the control patients (38 attempts for 
VFI 1 vs 22  attempts for VFI 2, p = 0.10) or in the group receiving Ed (34 
baseline vs 26  attempts with Ed. p = 034). Tire Q-T peak interval during 
ventneuler pacing did not vary with Ed. 
Conclusion, Edrophonium hydrochloride does not affect ventncular tibril- 
lotion induction m humans. The fact that increasing cardiac vogel activity by 
Ed does not increase VF thresholds suggests a direct role of sympathetic 
actwity rather than sympathetic/parasympathetic interaction. 
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~High  Efficacy of Steroid Treatment in Patients With 
Right Ventricular Outflow Tract Tachycardia 
I. Mendoza, F, Moleiro, J. Marques, A. Castellanos. F. Rodriguez, 
E. Troncoso, R. ReveI-Chion, A. Matheus, J. Guerrero, H. Acquatella. 
Central University el Wnezc~la. Caracas, Venezuela: University of Miami 
School of Medicine, Miami. Florida, USA 
Ob/ective: To evaluate the effects of steroid treatment on patients (pts) with 
.ght ventricular outflow tract ventdcular tachycardia (RVOT-VT). 
Background: The pathologic substrate of RVOT-VT is difficult to ascedain. 
The use of codicosteroids in RVOT-VT has not been evaluated. 
Methods: A series of 14 consecutive pts (10 temales and 4 males). Ages: 
41 ~ 14 years (range 20-65 years) with symptomatic RVOT-VT were ad- 
mitted to the study, Eleven had nonsustained VT and 3 sustained VT. Pts 
JACC February 1998 ABSTRA_C't-S : O~l 91A 
un@etwenl cfin~e-~l rand Irabof~t0ry evralu~bonfl, ECGs, che~t X,rray=, H~ter 
recordings, ech~ard~og~ram~, ~ignal ~ver~ged ECG~, asd inva~iv~ eleCtro- 
physiologic sh~lles, 
R_a~u#~; Twelve ptS h~ld Strip.lift,lily ruOlW'~l h~rtS and 2, 0rrbylhmog~n~c 
RV ~pla~,_~ VT w~ ~nduc~'¢ by ex~rmso ,n ~n p_t~ ~nd not .',~ob(e_ w,th 
pfogr~m~l stimu~t~n, Gorlicostero~d tl~r~py; prednisoflo, moan do~o 
rafter 1 ~th  el thet~y (g~f~f~!ty ~ff~f 10 (~/,~), No ~ff~l was ~ecn in 
4 Dt!k O~!nfl 9 the I0~t~W~up 4 W_S s~h0w~l t'.P~F'dnCe 0f VT l~Itt~r therapy 
w~t.h~lr~w~, wit_h a_bolit~Oe ~ the ~nlny~m~.~ ~ftef ~ s~ond ~ month tri~l with 
fl~tiVO thefi~py I0I pie with RVOT.VT. Further fot|~w~l~ 5tub.taft ~r~= f~t~i~l, 
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~ Ri0ht V~m~icu~r Ou_tfl.ow Tr=¢t T~¢hy©~!r¢!~ !n 
WO!NIf!" ~n~l~N!! ,  (|_eet~tlol~| nd 
F- l~ch~mskt, A#~J~ U~ve~y H~I~Ls, P- hdad~/~ot~a, PA USA 
_Bac3~gft~jt~: R~t~t v~r,t.,~c~r  ~ tacl~¥cardia (RVOT.Vr) is Chef 
q~.t~rb~etJ by rep~t~t~e P6t~ ~ PVC~ ~ a ~ft t~.n~_ ~be-arch b~o~k and 
infetim ares ~¢x Jy  ~th VT tyl~ally p _r~.witated by exer~se. 
Met t '~:  S~teen C~ecut~ve ~m~,en (m~an age = 46, r'dnge ~ )  
who ~eSen{ed with RVOT-VT were interviewed to determine if predictable 
ex~¢n m ~ymptpmah¢ VT ~s= associatf~! with known pen~:~s of in- 
creased ho~_  f l~t i~es .  _Spe,~ty. the ~nt  was asked whether 
they expertanCed any pred.'table exa~:ed~at~m  VT, if a pos~Jve response 
Wars rL=ceived, the ~nt  was asked whether FfVOT-V'~ OCcuffed with pre- 
d~d i ty  w~d~ stxess, exemise, of m a time of pmmer~lmal, pertmenopah~sal, 
or gestatJaaeJ penedS. Eight p~s ~ere premenopaasal nd 2 were never pceg- 
nanL 
Resu~s: Repo,-ted as the frequency 01 a di~nct, predictable xaceft~at~on 
m RVOT-~q'. 
U~o~f~te 3/16 (19%) 
4;16 (25%) 
E~eP=t.~e t/16 (6%) 
P~.~-qoPa '~u~.aJ o~t 6,'16 t35%} 
~na J  octly Ii14 t7%) 
TO~J w~th Grmon~J S~ft5 11116 (6~1%) 
Co,'tclus~ons: In women, RVOT-VT appea~ to be predictably exacer- 
bated by gender specific hormonal fluctuations that occur w~th menopaus~ 
fiesta~on and dunng the premenstrual period. Precipitation by exerose is 
unc~n'b"non. 
New Markers for Risk Stratification Serologic 
in Ischemic Syndromes 
Monday, March 30, 1998, 4:00 p.m.-5:30 p.m. 
Georgia World Congress Center, Room 267W 
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~'~ "Low-RiSk" Chest Pain Patients be at Risk may High 
for Cardiac Events: Prospective Use of Troponin T 
for Risk Stratif ication 
R.J. Parmar, G. Abmo, B.F. Uretsky, M.S. Runge, G,H. d~Filippi. Umversdy 
of Texas Medical Branch, Galveston, Texas. USA 
Cardiac tmponin T (TnT) has shown prognostic value in chest pain (CP) 
patients (pts) with ischemic EGG changes. However, in "tow nsk" CP pts who 
undergo expedited evaluation in chest pain units, little is known about tire 
diannoStiC and prognostic value of TnT. 
Methods: "Low-nsk" CP pts were defined as having < ~ MI risk (Goldman 
et at: NEJM 1989; 318: 797) with no new ST/'r changes. We prospectively 
evaluated 414 pts who met these cnteria~ CKMB and TnT (EUSA) were drawn 
simultaneously __.10 hrs after CP onset. Positive (+) CKMB was defined ~LS 
25 ng/ml, +TnT >0.1 ng/ml and CAD >70% shanosis by angi0graphy. 
Resu/ts: TnT was + in 37/414 (9%) pts. of whom 20 (54%) had +CKMB. 
TnT+ pts (vs TnT- pts) had a higher prevalence ot typical CP (46=/0 vs 20%, p = 
0.001), diabetes (46% vs 24"/0, p = 0.003), old ;r age (59% vs 51%, p = 0.Q02) 
but no difference (p > 0.05) in gender, hypertension, hypemholesterOlemia, 
smoking or prior MI hx. Of the 32 TnT+ pts who underwent angiography, 
90% had significant CAD [27% 1 vessel (V). 40% 2V, 23% 3V] with 100% 
occlusion present in 47%. Follow-up was obtained in 94% of pts (mean 264 :E 
tL~9 @ys) Multipha lOgiStic r~jr~.~ion Of TnT, CKMB ~nd Clerical r~,~ fE=~f~ 
I~VI~I(~I th~t only @ .TnT w~.~  l~gnifle,~t g¢~lOr fO~ ff~ 0e~Ufr~;~= O~
000f] wh~r~S ~ combiner Went r~l~ (d¢.~th, Mt, r ~ , ~  for CHF 0~ 
-= ~,7, 95%CI I~LL~'=6,0, p ~. 0,014) ll.nd a~ts~ (OR ~ ~,3, ;~%CI t 3 -~,  p 
~- 0 007). 
event~, 
4:!5 
~ Vsl~e of Mark~rl O! Myo~ardlal Injury and . 
I ntr=!¢oronaw Thrombl,llt in Rltk lltrl!t!fl¢~_~ ov 
Potlonttm ~t~lmtl~l to tn Em~l(mCy !~rtmqmt 
Wifh Ch~t !~|~ 
A.F, ,~one!, Y, (~wi~, L, Perkin~, N, Flne~rg, R,~ Wilen~Q/ Kt~P.f~rt 
Inst~t!~te atCar~o ~logyttr~arL~ Un~v~tt~, I~nat~i~ I ndi~===. U~A 
As the pafhe~nesis ot acute corenaq/synclr0m~ revolves throm~us fo~- 
marion, followed by my~:,/te injury, ,:!tiaralining the law.IS O~ m~du~ffi 0t 
~r0ent~a fom~tion aloflg w~ih m,~rkl~r~ ~ myocy~ injury may L:~rmitl~ 
patients (ptS) at n~ to~ tutme cardiac events. W~ deten~ined the If~vals of 
serum fr0p0~in I (Tnl), myo~m light chain 1 (MLC1), myOg/0~= n (~o) 
unne fibnnopeptide A (FPA) in 245 pts (M~_n Ag~ 5~2. 46% femv~_) W a-- 
sent~ to an ED with chest pare, Follow up cardiac events were defined as 
car0iac death, my~m infarction (MI), ~nstabte angina (UA) an~ ~rofi~y 
rev~en a(~umng ~g lt~ 6 ~ l~lowing pts' initial ~rc=~e~ 
tstiOn. ~rtng follow up 68 patents deva~ ~1 naw car~ events; 10 Ip~ 
died, 13 had MI, 50 had UA, and 28 were ~ lar i~ .  Using utw~naf~ 
analysis, FPA was the Only marker sig~dwantly p~ing  ~th  (p = 0 .~) ,  
MI (p = 0.02), UA (p = 0.02) as well as confined evenls (p < 0,~t ) .  None 
of the markers were predictive of long harm ~l ,~-~t ion .  Using 5xj~tc 
multivana~e r gression analysis, FPA waS the strongest predictor of ~zn:fiac 
events (p = 0.QOC2. OR = 3.6) followed by Tnl (p = 0.046, OR = 2.0) while Mb 
and MLC1 were not signifiGant. Udr~e FPA i~=ntif~s pts af t.agh risk for future 
ca~ac e,~enha. Sm~'e FPA is a marker of ~rem~,  intrac~¢~ary ~ron~us 
m~y be a more s~gnificant pre(~ctor Of outcome in an unsel~-'tsd population 
of chest p~n pts. 
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~ Positive Serum Markars in Patients WLth CheSt Pain 
in the Emergency Department Have Prognostic 
Significance 
R. From'n, D. Meyer, A. Boudmaux, J. Z~mmerman, C.-C. Wun. B Daws, 
R Smelling, G. Herb, R. Rebaits. Baylor Coltege el Medicine and 
Umv~ra;ty of Texas Health Science C~nter, HOuston, TX, USA. 
Backmound: Mdt~o~s ot patients present annually w~th cl~est pain, but 
10% have ~ta l  mfarc~an (MI). We recently repOrted comparative sen. 
sitivity and specificity (sens/spec) c; available markers for early and late 
diagnosis of MI. I-he.ever, o~timal interpretation requires tong-term prngrms. 
tic follow-up data. 
Methods: 30 day and 6 month follow.up of 955 consecutive patienha w=th 
chest pare were enrolled in a prospective, multicanhar, douf~e-bllnd 5~.  
The prognostic sign~cance of MEI CK subferms, trepo~in t ar~ T, myoglot~n 
and Total CK to predict death end revasculariZati0n (RV) was asceffained. 
ResultS: MI waS diagnosed in 119 by CK MB mass and unstable ~gma 
(UA) in 203 by clinical cmena. Of patients with UA. CK MB subfonl~ were 
posilNe in 29%, rnyoglobin, 24%; troponln I, 20%; treponin 1". 15%; and CK 
MB mass, 15%. Follow-up ~t ~ G~'~ o~d 6 months in 824 and 724 patients 
respectNely showed mortati~as of 2.8% and 4.14% respectively. $tx-mo~th 
mortality was 5.6% in MI, 4.4% in UA, and 3.0% in other patients (p < 0.025). 
RV occurred in 9.3% at 6 mantles. A ¢,.OSit;vO '~st on e~C,h of the m_m,'ke.,s 
except myoglobin was predictive of RV (relative nsk (RR) 1.41 to 2.1, p < 
0.05) The composite enrJpeint of death or RV occurred in 107 patients by 6 
months and a positive result on eacl~ of the markers was predtctnm O! this 
(RR 1.43-.2.0. p < 0.05), 82% Of patients with MI were pos~ve for CK MB 
subforms in the Emergency Department tED) within 1 hour of am%'al. The 
RR of death or RV for non-MI patients who teSt positive on each of these 
markers was greater that 1.0 but did not reach slatistical signif-~..ance. 
Conc/usions: Early markers (CK MB subformS and myoglo~in) posibve in 
patients with chest pain Shodly after arrival tn the Emergency Department 
have diagnostic and prognostic significance as do late markers (tml~nin T, I 
and total CK MB) whether in patients w=th MI or UA. 
